Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$BDSX Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.71 up 55.62% YoY • Reported revenue of $26.86M up 34.18% YoY • Biodesix expects total revenue of $108-114 million for full year 2026, with the midpoint representing approximately 25% growth over 2025, and maintains gross margin guidance of approximately 80% for 2026.

Price since post

Full Details

Advertisement|Remove ads.